8-K
Current Report
Alaunos Therapeutics, Inc. Filed Acc 0001213900-20-038252
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea130172-8k_ziopharm.htm…